Clinical Trial Update: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing survival with recombinant human neuregulin-1β in chronic heart failure; results status currently Unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• recombinant human neuregulin-1β (neuregulin-1β)

Snippet

Sponsor: Zensun Sci. & Tech. Co., Ltd. | Conditions: Chronic Heart Failure | Phase 3 | Status: UNKNOWN